Jeroen B. van Beek - 16 Nov 2021 Form 4 Insider Report for Allovir, Inc. (KLRS)

Role
Chief Commercial Officer
Signature
/s/ Brett Hagen, as Attorney-in-Fact
Issuer symbol
KLRS
Transactions as of
16 Nov 2021
Net transactions value
-$321,262
Form type
4
Filing time
18 Nov 2021, 15:30:45 UTC
Previous filing
01 Oct 2021
Next filing
03 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALVR Common Stock Sale $321,262 -15,203 -3.6% $21.13* 403,392 16 Nov 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock, and does not represent a discretionary trade by the reporting person.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.52 to $21.51. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.